Home › Psoriatic Arthritis › North Carolina
Psoriatic Arthritis clinical trials in North Carolina
6 studies for Psoriatic Arthritis are looking for participants at sites in North Carolina.
Cities in North Carolina
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- DJL Clinical Research, Charlotte
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07286058A Remotely Conducted Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
- University of North Carolina at Chapel Hill, Chapel Hill
RecruitingPhase 4
Ages 18 and older · Women · Updated Nov 3, 2026 · NCT07654751Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- University of North Carolina at Chapel Hill, Chapel Hill
- Levine Children's Hospital / Carolinas Medical Center, Charlotte
- Duke Children's Hospital & Health Center, Durham
- and 1 more
RecruitingObservational study
Up to age 21 · All sexes · Updated Oct 21, 2026 · NCT02418442A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
- Up0122 106, Chapel Hill
- Up0122 102, Durham
RecruitingPhase 1
Ages 18 and older · Women · Updated Sep 18, 2026 · NCT06888193A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- University of North Carolina - Children's Hospital /ID# 259286, Chapel Hill
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 1, 2026 · NCT06100744Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
- Evidera, a PPD Business Unit /ID# 238688, Morrisville
RecruitingObservational study
All ages · Women · Updated Jul 17, 2025 · NCT04846959From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.